Pharmafile Logo

News and Press Releases

New Reverse Osmosis (RO) pure water dialysis system unveiled by NIPRO at ERA 2025

19 June 2025 -- Osaka, Japan -- NIPRO announces the launch of LiniXia, a strategic addition to its dialysis portfolio in next-generation reverse-osmosis (RO) water treatment. The new LiniXia RO...

Category: Biotechnology, Drug Delivery, Other, Pharmaceutical
Posted: June 19, 2025

Nipro Medical Corporation
info@nipromed.com

Nipro announces major expansion with new medical device manufacturing facility in Greenville, North Carolina, US 

17 July 2024 – Greenville, NC, US — Nipro Medical Corporation, a leader in the global healthcare and medical device industry, proudly announces its significant expansion in the United States...

Category: Manufacturing and Packing
Posted: July 18, 2024

Nipro Medical Corporation
info@nipromed.com

Invizius’s Pioneering Dialysis Product H-Guard Completes First In-Human Clinical Study  

Study demonstrated safety and tolerability of H-Guard, a second generation complement regulator, designed to address serious immune system-driven complications of dialysis Encouraging biomarker data positions H-Guard for upcoming Acute Kidney...

Category: Biotechnology, Pharmaceutical
Posted: May 22, 2024

Invizius
Suite 2, Ground Floor Orchard Brae House, 30 Queensferry Road, Edinburgh, United Kingdom, EH4 2HS

ERS Genomics appoints John E Milad as Chief Executive Officer

13 May 2024 -- Dublin, Ireland -- ERS Genomics, the CRISPR licensing company, today announced the appointment of John E Milad as CEO, with immediate effect. John brings over 25...

Category: Drug Delivery, Drug Discovery
Posted: May 13, 2024

ERS Genomics
8th Floor, Block E, Iveagh Court, Harcourt Road, Dublin D02 YT22, Ireland